Suchergebnisse - "Spiekermann, Karsten"

PubPharm (40)

1

Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG)

enthalten in: Leukemia | 2024

von Ozga, M. | Nicolet, D. | Mrózek, K. | +37

2

Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML

enthalten in: Blood | 2023

von Roas, M. | Vick, B. | Kasper, M. | +21

3

Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning

enthalten in: Haematologica | 2023

von Eckardt, J. | Röllig, C. | Metzeler, K. | +30

CommentIn: Haematologica. 2023 Mar 01;108(3):668-669. - PMID 35708138

4

Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis

enthalten in: Cancer | 2022

von Pastore, F. | Pastore, A. | Rothenberg-Thurley, M. | +12

5

Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid Leukemia

enthalten in: Molecular cancer therapeutics | 2020

von Brauchle, B. | Goldstein, R. | Karbowski, C. | +23

6

A series of novel aryl-methanone derivatives as inhibitors of FMS-like tyrosine kinase 3 (FLT3) in FLT3-ITD-positive acute myeloid leukemia

enthalten in: European journal of medicinal chemistry | 2020

von Sellmer, A. | Pilsl, B. | Beyer, M. | +13

7

KIT D816 mutated/CBF-negative acute myeloid leukemia : a poor-risk subtype associated with systemic mastocytosis

enthalten in: Leukemia | 2019

von Jawhar, M. | Döhner, K. | Kreil, S. | +23

CommentIn: Leukemia. 2021 Jan;35(1):282-285. - PMID 33106623

8

Genetics of acute myeloid leukemia in the elderly : mutation spectrum and clinical impact in intensively treated patients aged 75 years or older

enthalten in: Haematologica | 2018

von Prassek, V. | Rothenberg-Thurley, M. | Sauerland, M. | +16

CommentIn: Haematologica. 2018 Nov;103(11):1758-1759. - PMID 30381416

9

The target landscape of clinical kinase drugs

enthalten in: Science (New York, N.Y.) | 2017

von Klaeger, S. | Heinzlmeir, S. | Wilhelm, M. | +45

CommentIn: Br J Cancer. 2018 Apr;118(7):936-937. - PMID 29545596

10

The new and recurrent FLT3 juxtamembrane deletion mutation shows a dominant negative effect on the wild-type FLT3 receptor

enthalten in: Scientific reports | 2016

von Sandhöfer, N. | Bauer, J. | Reiter, K. | +10